Document 5DJkj33Q2g0qDapMVOKoVNxRR

To: BenzConsort-TC@listserve.api.org <BenzConsort-TC@listserve.api.org> From: Bruce Jarnot <jarnotb@api.org> Cc: michael.g.bird@exxonmobil.com <michael.g.bird@exxonmobil.com>; Russell White <whiter@api.org>; John Wagner <Wagner@api.org>; mfitzsim@steptoe.com <mfitzsim@steptoe.com>; Bruce Jarnot <jarnotb@api.org> Bcc: Received Date: 2007-03-2320:48:11 GMT Subject: BHRC-TC... Monday TC Conf Call - 11 :OOam EDT Benzene Health Research Consortium Technical Committee (BHRC-TC) - 11 :OOAM Eastern Daylight Time was the consensus selection by Technical Committee members for Monday's conference call. .. AGENDA * Antitrust review * Technical review of the Cinpathogen/Fudan research proposal & criteria document (see attached 116-page bohunkus 1MB file "DPMEMasterFinaI3_18_07.doc") DIAL-IN INFORMATION * Day/Date: Monday, March 26th * Start time: 11 :OOAM EDT (1 OAM Central; 7AM Pacific) * Conference Line: 770-765-9147 (Toll Free: 866-443-0059) * PIN Code: 202-682-8473# (Bruce's phone number) Best Regards - Bruce. -----Original Message----From: michael.g.bird@exxonmobil.com [mailto:michael.g.bird@exxonmobil.com] Sent: Thursday, March 22,20078:02 PM To: Galvin, Jennifer B; stuart.cagen@shell.com Cc: Bruce Jarnot Subject: Re: SHS Urgent Action for the BHRC TC Jennifer & Stuart, Steve Bowes & I were the TC members on the BHRC Oversight call today and so I accepted on your behalf the urgent action for the TC to review the technical aspects of Richard Irons proposal received SH ELL-MCCLU RG-058785 this week, and as soon as its available, the tech content! tech milestones in Cynpathogen/ Fudan contract. Feedback from the TC is high priority and is needed ahead of the next week's Oversight meeting on Thursday March 29th. I believe that you would want to progress this best through a TC conference call e.g. for Monday and Bruce is prepared to set one up immediately. It was made very clear to all that it is critical to give this and other actions the highest attention/immediacy. Please confirm to Bruce that he should proceed with setting up a call and communicating to the TC members the urgent need to review the technical coverage of the proposal (& contract). Michael Michael G. Bird, PhD., DABT Toxicology & Environmental Sciences Division, ExxonMobil Biomedical Sciences, Inc. 1545 Route 22 East P.O. Box 971 Annandale, New Jersey 08801-0971 tel: 9087301060 fax: 908 730 1199 Email: michael.g.bird@exxonmmobil.com This document and all information contained within this electronic message may be privileged, confidential and exempt from disclosure under applicable law. It is intended only for the use of the individual(s) and/or SH ELL-MCCLU RG-058786 entity(ies) named above. If you are not the intended recipient, you are on notice that any unauthorized disclosure, copying, distribution, or taking of any action in reliance on the contents of the electronically transmitted materials is prohibited. Attachments: DPMEMasterFinaI3_18_07.doc SH ELL-MCCLU RG-058787